Peter S. Griffin

Most-cited papers

1. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.

   J. Trevaskis, Peter S. Griffin, Carrie R. Wittmer, B. Neuschwander-Tetri +6 more

   2012American Journal of Physiology - Gastrointestinal and Liver Physiology262 citations

   Semantic Scholar

   Save

2. Mechanisms of amylin/leptin synergy in rodent models.

   V. Turek, J. Trevaskis, B. Levin, A. Dunn-Meynell +7 more

   2010Endocrinology143 citations Open access

   Semantic Scholar

   Save

3. Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials

   Michael Grimm, Jenny Han, C. Weaver, Peter S. Griffin +3 more

   2013Postgraduate medicine67 citations

   Semantic Scholar

   Save

4. Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats.

   J. Trevaskis, V. Turek, Carrie R. Wittmer, Peter S. Griffin +6 more

   2010Endocrinology64 citations Open access

   Semantic Scholar

   Save

5. Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial.

   C. Wysham, L. Macconell, D. Maggs, Ming Zhou +2 more

   2015Mayo Clinic proceedings54 citations

   Semantic Scholar

   Save

6. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents

   J. Trevaskis, Cheng-Zao Sun, Jennifer Athanacio, Lawrence J. D'souza +9 more

   2015Diabetes, obesity and metabolism53 citations

   Semantic Scholar

   Save

7. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?

   J. Trevaskis, V. Turek, Peter S. Griffin, Carrie R. Wittmer +2 more

   2010Physiology and Behavior49 citations

   Semantic Scholar

   Save

8. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.

   Jason R. Clapper, Jennifer Athanacio, Carrie R. Wittmer, Peter S. Griffin +3 more

   2013European Journal of Pharmacology28 citations

   Semantic Scholar

   Save

9. Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics.

   Cheng-Zao Sun, J. Trevaskis, C. Jodka, Swetha Neravetla +6 more

   2013Journal of Medicinal Chemistry24 citations

   Semantic Scholar

   Save

10. Amylin/leptin synergy is absent in extreme obesity and not restored by calorie restriction‐induced weight loss in rats

    J. Trevaskis, Carrie R. Wittmer, Jennifer Athanacio, Peter S. Griffin +2 more

    2016Obesity Science & Practice23 citations Open access

    Semantic Scholar

    Save

11. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents

    J. D. Roth, Lawrence J. D'souza, Peter S. Griffin, Jennifer Athanacio +6 more

    2012Diabetes, obesity and metabolism22 citations

    Semantic Scholar

    Save

12. metabolic, biochemical and histopathological indices of nonalcoholic

    J. Trevaskis, Peter S. Griffin, Carrie R. Wittmer, B. Neuschwander-Tetri +6 more

    20123 citations

    Semantic Scholar

    Save

13. Glucagon-like peptide-1 (GLP-1) receptor agonism improves 1 metabolic, biochemical and histopathological indices of nonalcoholic 2 steatohepatitis (NASH) in mice. 3

    J. Trevaskis, Peter S. Griffin, Carrie R. Wittmer, B. Neuschwander-Tetri +5 more

    20110 citations

    Semantic Scholar

    Save

14. Diet-Induced Obese Rats Enhanced Amylin-Mediated Body Weight Loss in Estradiol-Deficient

    J. Trevaskis, V. Turek, Peter S. Griffin, J. K. Wilson +1 more

    20100 citations

    Semantic Scholar

    Save